Key Market Indicators
The country was number 11 in 2021, Germany came in first with $38,608,000. Italy, France and Poland respectively were numbers 2, 3 and 4 in this ranking. Sales of diabetes medicines in Slovakia are expected to reach $113.48 million by 2026, up 2.5% year-on-year from $98.56 million in 2021. Since 2001, the Slovak market has grown by an average of 5.7% each year. Slovakia ranked 19th in 2021, with Ireland taking the lead at $98.56 million. Canada, Spain and Italy followed in second, third and fourth place. Exports of Slovak insulin are predicted to reach $6.27 million by 2026, up 3.5% year-on-year from $5.12 million in 2021. Since 1999, Slovak supplies have decreased by 5.1% on average each year. Slovakia came 24th in 2021, with Greece ahead at $5.12 million. France, Italy and China ranked second, third and fourth respectively. Slovakia's insulin imports are projected to reach $42.53 million by 2026, up 1.8% year-on-year from $38.61 million in 2021. Since 1999, Slovak demand has grown by 3.4% on average. In 2021, Slovakia came 11th, with Germany in the lead at $38.61 million. Italy, France and Poland were ranked second, third and fourth respectively.
